AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS

Core Points - Amgen announced a $650 million expansion of its U.S. manufacturing network, which is expected to create nearly 750 jobs [2][3] - The investment will enhance drug production at the biologics manufacturing facility in Juncos, Puerto Rico, and integrate advanced technologies [2] - This expansion reflects Amgen's commitment to U.S. biomanufacturing and aims to strengthen the global supply chain [2] Investment and Job Creation - The planned investment will create hundreds of new jobs, including construction and highly skilled manufacturing roles [2] - Amgen's total investment in manufacturing and R&D since the Tax Cuts and Jobs Act of 2017 exceeds $40 billion [2] Regional Impact - The expansion is expected to bolster U.S. supply chain security through reshoring and enhance Puerto Rico's position as a biopharmaceutical hub [2] - Puerto Rico has over 60 years of expertise in the biopharmaceutical sector, supported by a skilled workforce and infrastructure [2] Recent Investments - This announcement follows Amgen's recent investments, including a $600 million science and innovation center in California and $900 million in Ohio [3] - Additionally, Amgen has made a $1 billion investment in North Carolina for manufacturing expansions [3] Company Overview - Amgen is a leader in biotechnology, focusing on innovative medicines for serious diseases, with a strong pipeline for cancer, heart disease, and rare diseases [4] - The company has been recognized as one of the "World's Most Innovative Companies" and is part of the Dow Jones Industrial Average and Nasdaq-100 Index [5]